Dis-Chem sales rise on Better Rewards, while interim earnings and dividend fall
South African pharmacy retailer Dis-Chem grows revenue in the six months ended 31 August 2026 even as consumer spending remains under pressure. The stronger sales contribution from its Better Rewards loyalty programme does not prevent earnings per share and the interim dividend from declining as operating costs rise.
Highlights
- Dis-Chem's group revenue rises 8% to R23 billion for the six months ended 31 August 2026, driven by Better Rewards programme adoption and membership growth.
- Basic earnings per share fall more than 13% to 64.1 cents and interim dividend drops 12.9% to 25.62 cents per share due to rising costs, especially in retail employment expenses.
- Shares fall 8% on Friday morning from R27.95 to R25.49 as expenses climb 12.1% and earnings outlook remains pressured by ongoing investment in new stores and X, bigly labs.
Better Rewards drives revenue growth
As reported by Moneyweb, JSE-listed Dis-Chem says group revenue rises 8% to R23 billion in the six months ended 31 August 2026, with the increase largely driven by the Better Rewards programme despite temporary price deflation across 45% of front shop retail sales.One year after its October 2025 launch, Better Rewards has returned R1.5 billion in instant value to customers, in addition to retail promotional activity. Active membership grows 27% to 8.2 million, including 760,000 reactivated members and 980,000 new members, while members account for 86.1% of sales.
The company says Better Rewards brands now make up 45% of front shop retail sales. It adds that shopping frequency among active members who were already shopping before the programme launch increases by two additional visits, while average basket value rises 3.5%.
Wholesale revenue grows 9.6% to R18.4 billion during the period. Revenue to Dis-Chem's own retail stores, still the largest contributor, grows 10.3%, while external revenue to independent pharmacies and The Local Choice franchises increases 7.0% from the comparable period.
Cost pressure weighs on earnings outlook
Higher sales do not translate into earnings growth, with basic earnings per share falling more than 13% to 64.1 cents and headline earnings per share declining 12.8% to 64.3 cents. Dis-Chem declares an interim dividend of 25.62 cents per share, down 12.9% from the prior comparable period.Group expenses increase 12.1% over the comparable period, while retail expenses rise 13.7% as the company continues investing in new stores and X, bigly labs. Retail employment costs, which account for 53.0% of total retail expenses, climb 12.8%, adding further pressure to margins.
Dis-Chem says it anticipates a more even distribution of earnings across 1H2027 and 2H2027 because of the higher invested cost base for X, bigly labs in 2H2026, which it expects to support stronger full-year earnings performance. The market reaction is negative, with the company's share price sliding 8% in Friday morning trade from R27.95 to R25.49.
Our earlier coverage on executive pay at JSE Top 200 companies examined how CEO and CFO remuneration is rising, with variable incentives growing much faster than fixed pay. We also outlined new Companies Act requirements that increase transparency through pay-ratio disclosures and add a binding shareholder vote on remuneration, tightening governance pressure on listed firms.